Rachel Rosovsky /LinkedIn
Oct 31, 2025, 02:06
Rachel Rosovsky Presents STORM-PE RCT Results at VIVA 2025
Rachel Rosovsky, Hematologist at Massachusetts General Hospital, posted on LinkedIn:
”The first-and only-RCT demonstrating the efficacy of anticoagulation (AC) for the treatment of PE was conducted in 1960 and included 73 patients. Join us at VIVA 2025 to see how far we’ve come. On behalf of the entire STORM-PE team and in collaboration with PERT Consortium, I will be presenting the clinical and functional outcomes of the first RCT comparing mechanical thrombectomy plus AC versus AC alone in patients with acute intermediate–high-risk PE.
Robert Lookstein, Prof.Dr.Stavros Konstantinides, Ido Weinberg, John Moriarty, Sahil Parikh, Suhail Dohad, Richard Channick, Richard Davis, The PERT Consortium®”
Stay updated with Hemostasis Today.
Anticoagulation
Deep venous thrombosis
DVT
Health
Hematology
Hemostasis
Hemostasis Today
Ido Weinberg
John Moriarty
Medicine
PERT Consortium
Prof.Dr.Stavros Konstantinides
Pulmonary embolism
Rachel Rosovsky
Richard Channick
Richard Davis
Robert Lookstein
Sahil Parikh
STORM-PE
Suhail Dohad
thrombosis
Venous Thrombosis
VIVA 2025
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers